Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 25, 2012

Primary Completion Date

July 6, 2017

Study Completion Date

July 1, 2021

Conditions

Diffuse Large Cell Lymphoma Relapsed/Refractory

Interventions

DRUG

Ofatumumab

1000 mg IV days 0, 7, 14, 21

DRUG

Etoposide

10 mg/Kg IV over 24 hours daily, days 1-4

DRUG

Cytarabine

2000 mg/m2 IV twice daily, days 1-4

Trial Locations (1)

University of California, San Francisco, San Francisco